These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36336848)

  • 1. Cardiac computed tomography following Watchman FLX implantation: device-related thrombus or device healing?
    Kramer AD; Korsholm K; Jensen JM; Nørgaard BL; Peelukhana S; Herbst T; Horton R; Kar S; Saw J; Alkhouli M; Nielsen-Kudsk JE
    Eur Heart J Cardiovasc Imaging; 2023 Jan; 24(2):250-259. PubMed ID: 36336848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Device-Related Thrombosis Following Left Atrial Appendage Occlusion: A Comparison Between Cardiac Computed Tomography and Transesophageal Echocardiography.
    Korsholm K; Jensen JM; Nørgaard BL; Nielsen-Kudsk JE
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008112. PubMed ID: 31514523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Computed Tomography Angiography for Device-Related Thrombus Assessment After WATCHMAN FLX™ Occluder Device Implantation: A Single-Center Retrospective Observational Study.
    Miller T; Hana D; Patibandla S; Guzman DB; Avalon JC; Zeb I; Kadiyala M; Mills J; Balla S; Kim C; Lisle M; Kawsara M; Raybuck B; Daggubati R; Sengupta PP; Hamirani YS
    Cardiovasc Revasc Med; 2022 Aug; 41():35-46. PubMed ID: 35140053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study.
    Galea R; Mahmoudi K; Gräni C; Elhadad S; Huber AT; Heg D; Siontis GCM; Brugger N; Sebag F; Windecker S; Valgimigli M; Landolff Q; Roten L; Amabile N; Räber L
    Europace; 2022 Oct; 24(9):1441-1450. PubMed ID: 35253840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracardiac echocardiography-guided implantation of the Watchman FLX left atrial appendage closure device.
    Turagam MK; Neuzil P; Petru J; Hala P; Mraz T; Baroch J; Lekesova V; Prokopova M; Dukkipati SR; Reddy VY
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):717-725. PubMed ID: 33533089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world survival data of device-related thrombus following left atrial appendage closure: 4-year experience from a single center.
    Bai Y; Xue X; Duenninger E; Muenzel M; Jiang L; Keil T; Fazakas A; Yu J
    Heart Vessels; 2019 Aug; 34(8):1360-1369. PubMed ID: 30820642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracardiac Echocardiography to Guide Watchman FLX Implantation: The ICE LAA Study.
    Nielsen-Kudsk JE; Berti S; Caprioglio F; Ronco F; Arzamendi D; Betts T; Tondo C; Christen T; Allocco DJ
    JACC Cardiovasc Interv; 2023 Mar; 16(6):643-651. PubMed ID: 36764917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition from WATCHMAN V.2.5 to WATCHMAN FLX for closure of the left atrial appendage: echocardiographic and clinical findings.
    Sakriss C; Roehl P; Schwenzky A; Hoyme M; Ebelt H
    Open Heart; 2023 Mar; 10(1):. PubMed ID: 36918230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Watchman FLX Device: First European Experience and Feasibility of Intracardiac Echocardiography to Guide Implantation.
    Korsholm K; Samaras A; Andersen A; Jensen JM; Nielsen-Kudsk JE
    JACC Clin Electrophysiol; 2020 Dec; 6(13):1633-1642. PubMed ID: 33334441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of detecting peri-device leak and incomplete endothelialization by cardiac CT angiography in atrial fibrillation patients post Watchman LAAC combined with radiofrequency ablation.
    Zhao MZ; Chi RM; Yu Y; Wang QS; Sun J; Li W; Zhang PP; Liu B; Feng XF; Zhao Y; Mo BF; Chen M; Zhang R; Gong CQ; Yu YC; Li YG
    J Cardiovasc Electrophysiol; 2021 Oct; 32(10):2655-2664. PubMed ID: 34428342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ALSTER-FLX Registry: 3-Month outcomes after left atrial appendage occlusion using a next-generation device, a matched-pair analysis to EWOLUTION.
    Paitazoglou C; Meincke F; Bergmann MW; Eitel I; Fink T; Vireca E; Wohlmuth P; Veliqi E; Willems S; Markiewicz A; Grygier M
    Heart Rhythm; 2022 Jun; 19(6):917-926. PubMed ID: 35181483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
    Galea R; De Marco F; Meneveau N; Aminian A; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Babongo Bosombo F; Heg D; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Räber L; Valgimigli M
    Circulation; 2022 Mar; 145(10):724-738. PubMed ID: 34747186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world experience with the new Watchman FLX device: Data from two high-volume Sicilian centers. The FLX-iEST registry.
    Vizzari G; Grasso C; Sardone A; Mazzone P; Laterra G; Frazzetto M; Sacchetta G; Micari A; Tamburino C; Contarini M
    Catheter Cardiovasc Interv; 2022 Jul; 100(1):154-160. PubMed ID: 35592941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device.
    Korsholm K; Kramer A; Andersen A; Saw J; Nørgaard BL; Jensen JM; Nielsen-Kudsk JE
    J Interv Card Electrophysiol; 2023 Mar; 66(2):391-401. PubMed ID: 35951214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed endothelialization of watchman device identified with cardiac CT.
    Sivasambu B; Arbab-Zadeh A; Hays A; Calkins H; Berger RD
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1319-1324. PubMed ID: 31257658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.
    Kubo S; Mizutani Y; Meemook K; Nakajima Y; Hussaini A; Kar S
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1380-1386. PubMed ID: 29759668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry.
    Sedaghat A; Nickenig G; Schrickel JW; Ince H; Schmidt B; Protopopov AV; Betts TR; Gori T; Sievert H; Mazzone P; Grygier M; Wald C; Vireca E; Allocco D; Boersma LVA;
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1019-E1024. PubMed ID: 33417282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, mechanisms and impact of residual patency and device-related thrombosis following left atrial appendage occlusion: a computed tomography analysis.
    Agudelo VH; Millán X; Li CH; Moustafa AH; Asmarats L; Serra A; Arzamendi D
    EuroIntervention; 2021 Dec; 17(11):e944-e952. PubMed ID: 34219668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.